(Q38955527)

7 September 2017

title

Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation (English)

1 reference

7 September 2017

10

Ulrike Kuckelkorn

1 reference

7 September 2017

Kathrin Textoris-Taube

3

Kathrin Textoris-Taube

0 references

Michele Mishto

1

Michele Mishto

0 references

Antje Voigt

Antje Voigt

9

0 references

Michael Stumpf

11

Michael P H Stumpf

1 reference

7 September 2017

Juliane Liepe

2

1 reference

7 September 2017

Kathrin Textoris-Taube

3

1 reference

7 September 2017

Christin Keller

4

1 reference

7 September 2017

Petra Henklein

5

1 reference

7 September 2017

Marion Weberruß

6

1 reference

7 September 2017

Burkhardt Dahlmann

7

1 reference

7 September 2017

Cordula Enenkel

8

1 reference

7 September 2017

Peter M Kloetzel

12

1 reference

7 September 2017

language of work or name

English

0 references

publication date

20 November 2014

1 reference

European Journal of Immunology

7 September 2017

published in

1 reference

7 September 2017

volume

44

1 reference

7 September 2017

issue

12

1 reference

7 September 2017

page(s)

3508-3521

1 reference

Immunoproteasome in cancer and neuropathologies: a new therapeutic target?

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Proteolysis, proteasomes and antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Consensus motifs and peptide ligands of MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Mice completely lacking immunoproteasomes show major changes in antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Different proteasome subtypes in a single tissue exhibit different enzymatic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Proteasomes in immune cells: more than peptide producers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Driving forces of proteasome-catalyzed peptide splicing in yeast and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Assessment of proteasomal cleavage probabilities from kinetic analysis of time-dependent product formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

The unique functions of tissue-specific proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Quantitating protein synthesis, degradation, and endogenous antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Making sense of mass destruction: quantitating MHC class I antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

An altered T cell repertoire in MECL-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Modeling the in vitro 20S proteasome activity: the effect of PA28-alphabeta and of the sequence and length of polypeptides on the degradation kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Age dependent impact of LMP polymorphisms on TNFalpha-induced apoptosis in human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Altered peptidase and viral-specific T cell response in LMP2 mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

The 20S proteasome splicing activity discovered by SpliceMet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

MHC class I expression in mice lacking the proteasome subunit LMP-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

MHC-linked LMP gene products specifically alter peptidase activities of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

Interferon-gamma induces different subunit organizations and functional diversity of proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

7 January 2021

Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

7 January 2021

Circulating proteasomes are functional and have a subtype pattern distinct from 20S proteasomes in major blood cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

7 January 2021

Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

7 January 2021

Rates of Processing Determine the Immunogenicity of Immunoproteasome-Generated Epitopes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444902

7 January 2021

Identifiers

DOI

10.1002/EJI.201444902

1 reference

release_ogi7qpeivvd4xmjgll4xuxfsdq

7 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ogi7qpeivvd4xmjgll4xuxfsdq

24 November 2022

mapped directly with Wikidata item

1 reference